This audio program contains contains highlights from two case-based daylong CME meetings our group hosted for medical oncologists in Los Angeles and New York City. Like all of our live events, the primary purpose of these gatherings was for us to interact with physicians in practice to better understand their education needs.

To better accomplish this goal, we commonly utilize an innovative wireless “chat room” setup that provides each attendee with a portable computer throughout the event. This allows participants to continuously provide input to our faculty panel, but even more importantly, it encourages them to pose questions that are usually answered by investigators as part of the meeting or typed in the chat room. Below, find a sampling of the most common queries and comments that emerged, many of which are discussed in the enclosed program.

— Neil Love, MD
NLove@ResearchToPractice.com

EDITOR'S NOTE
  Common questions about breast cancer from oncologists in community practice
CASES DISCUSSED
  Case 1: An active 79-year-old woman with a 7.5-centimeter, Grade II, ER/PR-positive, HER2-negative breast cancer with lymphovascular invasion and three positive nodes (from the practice of Dr Martha A Tracy)
  Case 2: A 41-year-old premenopausal woman with an ER/PR-positive, HER2-positive infiltrating ductal carcinoma and six positive lymph nodes (from the practice of Dr Herbert I Rappaport)
  Case 3: A 68-year-old woman with disease progression 10 years after presenting with hormone receptor-positive diffuse metastatic disease to the bone (from the practice of Dr Ghaleb A Saab)

  Case 4: A 91-year-old woman with dementia who was diagnosed with Stage II, ER-positive, lymph node-negative breast cancer 15 years ago and now has diffuse bone metastases (from the practice of Dr Juliann M Smith)
  Case 5: A 41-year-old surgically postmenopausal woman with a 3.5-centimeter, ER/PR-positive, HER2-positive tumor and two positive lymph nodes (from the practice of Dr Herbert I Rappaport)
  Case 6: A 45-year-old premenopausal woman with a 0.7-cm, ER/PR-positive, HER2-positive tumor with 25 percent high-grade DCIS and an Oncotype DX™ recurrence score of 16 (from the practice of Dr Steven W Papish)
  Case 7: A woman who presented in 1989 with an infiltrating lobular carcinoma and 21 positive nodes and was treated with adjuvant chemotherapy and tamoxifen and then develops metastatic disease and is treated over the next 11 years with a variety of chemotherapeutic and hormonal agents (from the practice of Dr Pamela Drullinsky)
  Case 8: A 35-year-old woman with a 3.5-cm, ER/PR-positive, HER2-positive infiltrating ductal carcinoma and two positive sentinel lymph nodes treated on the nontrastuzumab- containing arm of the Intergroup N9831 trial (from the practice of Dr Pamela Drullinsky)
   
 

Breast Cancer Update:
A CME Audio Series and Activity

Faculty Disclosures | Editor's Office